Accumulated Treatment Cost of New Therapies in Multiple Myeloma- Comparing the Combination of Daratumumab, Bortezomib and Dexamethasone with Carfilzomib and Dexamethasone For WHO Have Received at Least One Prior Therapy in Brazil
Abstract
Authors
C Del Rey E Asano